Showing results (1671-1680 of 4,166) with videos related to

Sort By:
Pageof 417
Translational Cancer Research|October 29, 2025
Constructing a chemokine-based model and identifying CCL17 as a core biomarker associated with immune infiltrates in thyroid cancerMimi Zhang, Bing Zou, Qiang Li, et al.
Translational Cancer Research|October 29, 2025
Neochlorogenic acid inhibits gastric cancer cell growth through apoptosis and cell cycle arrestWenqiang Sun, Yongchao Li, Menglong Xu, et al.
Translational Cancer Research|October 29, 2025
Real-time prognosis prediction with conditional survival analysis for skull base chordoma based on SEERXiaojia Zhang, Xiaosheng Chen, Jiajie Gu
Translational Cancer Research|October 29, 2025
Prognostic difference of single metastasis in different sites of hepatocellular carcinoma: a population-based studyYingjie Zhuang, Qing Chang, Wenhui Liu, et al.
Translational Cancer Research|October 29, 2025
B3GNT3 is an oncogenic and prognostic biomarker in human tumors via pan-cancer analysis combined with experimental validationKe Shen, Xinhuai Dong, Chong Zeng, et al.
Translational Cancer Research|October 29, 2025
Combination of Danggui Buxue Tang and concurrent chemoradiotherapy improves treatment outcomes by strengthening B cell immunity in patients with nasopharyngeal carcinoma-a double-blind, randomized trialHe-Yuan Hsieh, Shih-Neng Yang, Ming-Yu Lien, et al.
Translational Cancer Research|October 29, 2025
Establishment of a prognostic model and immune profiling based on phagocytic regulatory genes in hepatocellular carcinomaXiaodong Meng, Qiufang Wang, Yuan Tian, et al.
Translational Cancer Research|October 29, 2025
KCNJ11 as a prognostic and therapeutic target in colon adenocarcinomaJie Chen, Fuyi Xie
Translational Cancer Research|October 29, 2025
Development of a mitochondrial permeability transition-driven necrosis-linked lncRNA signature for forecasting prognosis and treatment of lung adenocarcinomaWeibin Luo, Dongfang Li, Da Yao
Translational Cancer Research|October 29, 2025
Clinical features as prognostic markers in patients with solid tumors treated with programmed cell death protein 1/programmed cell death-ligand 1 inhibitors: a retrospective cohort studyYanli Liu, Zhe Meng, Lei Hong, et al.
Pageof 417